---
created: 2025-04-13
updated: 2025-04-13T10:53
id: eKdcvS4GwC
specialty: pharmaco
specialty_id: 479
tags:
  - source/ak-original-decks::step-1::lolnotacop::drugs
  - "source/ak-step1-v11:": 
  - theme/amboss::hematonco
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::04-cancer-drugs::06-other-cancer-drugs
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::04-pathology::29-chronic-myeloproliferative-disorders::chronic-myelogenous-leukemia
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::22-imatinib-dasatinib-nilotinib
  - "source/ak-step1-v11:": 
  - theme/ome::06-inflammation-neoplasia::08-cycle-chemo
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/pixorize::01-immunology::07-leukemias-&-lymphomas::03-cml
  - "source/ak-step1-v11:": 
  - theme/pixorize::02-biochem::22-onc-drugs::18-imatinib,-dasatinib
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::11-oncology::imatinib,-dasatinib
  - "source/ak-step1-v11:": 
  - theme/sketchypath::10-myeloid-&-lymphoid::01-myeloid-disorders::02-acute-myeloid-leukemia-(aml)-&-chronic-myeloid-leukemia-(cml)
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::08-antineoplastics::03-kinase-inhibitors-&-monoclonal-antibodies::01-imatinib,-erlotinib,-sorafenib,-sunitinib,-vemurafenib"
type: flashcard
---

# Question
Which kinase inhibitor can be used to treat CML due to t(9;22) of BCR-ABL?   **imatinib 'n' dasatinib::tyrosine kinase inhibitors**

---

# Answer
specifically, a tyrosine kinase inhibitor